Cargando…
Can exenatide flatten the post-prandial glucose curve in type 1 diabetes?
Autores principales: | Boughton, Charlotte K., Hovorka, Roman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729374/ https://www.ncbi.nlm.nih.gov/pubmed/33313280 http://dx.doi.org/10.21037/atm-20-3654 |
Ejemplares similares
-
Exenatide at mealtimes in type 1 diabetes—no MAG1C with exenatide, or with other glucagon-like peptide-1 receptor agonists
por: Doggrell, Sheila A.
Publicado: (2020) -
The impact of “flattening the curve” on Generation Z
Publicado: (2020) -
Let Us Flatten the Infodemic Curve…
por: Geetha Dharmesh, Balsarkar
Publicado: (2021) -
Prandial Insulin and the Systemic Appearance of Meal-Derived Glucose in People With Type 1 Diabetes
por: Vella, Adrian, et al.
Publicado: (2008) -
Closed-loop management of inpatient hyperglycemia
por: Boughton, Charlotte K., et al.
Publicado: (2019)